TrialCancer prevention research (Philadelphia, Pa.)2012

Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial.

Seema A Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.